EP. 1: Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome
Watch
EP. 2: Comparison of Guidelines From ADA and AACE
EP. 3: How Does the Potential for Weight Gain Influence Choice of Therapies?
EP. 4: Variables Involved When Adding Medications to Treat Diabetes
EP. 5: The Influence of Lipid Guidelines on Real-World Practice Patterns
EP. 6: Alternatives to Add-On Therapy for T2D and Hyperlipidemia
EP. 7: WellCare's Initiatives To Improve Care for Members With Diabetes
EP. 8: Partnering With Providers to Prevent or Delay Complications Related to Diabetes
EP. 9: The Role of Managed Care in Identifying and Counseling Patients With Prediabetes
EP. 10: Addressing the Effect of Polypharmacy on Medication Adherence
EP. 11: Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications
EP. 12: Considerations Regarding Statin Therapy
EP. 13: Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment
EP. 14: Advantages of Medications that Treat Multiple Conditions
EP. 15: Updates to Treatment Guidelines: Effects on Payers
EP. 16: Major Cost Drivers in T2D Management
EP. 17: Role of Early Intervention in Preventing Progression to T2D
EP. 18: How Drug Cost Influences Drug Selection
EP. 19: Impact of Cost on Patients' Access to Treatment
EP. 20: An Increased Emphasis on Individual Risk Factors and Goals
EP. 21: The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia
EP. 22: Role of the Health Plan in Providing Support to Members With Diabetes
EP. 23: The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia
EP. 24: Complexities in Diabetes Care in 2017
EP. 25: Diabetes: Shifting Mindset for Cardiovascular Benefits
EP. 26: Practical Implications of the CANVAS Trial
EP. 27: Understanding the Safety Data in CANVAS
EP. 28: GLP-1 Receptor Agonists and Cardiovascular Benefit
EP. 29: Examining Cardiovascular Outcomes Trials
EP. 30: Raising the Bar on Cardiovascular Benefit
